Treatment of chancroid with azithromycin

International Journal of STD and AIDS

Volumn 7, Issue SUPPL. 1, 1996, Pages 9-12

  Ballard, R C ^a   Ye, Htun ^a   Matta, A ^a   Dangor, Y ^a   Radebe, F ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Azithromycin; Chancroid; Haemophilus ducreyi; HIV

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; ERYTHROMYCIN;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAEMOPHILUS DUCREYI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; ULCUS MOLLE;

EID: 0030027229     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961917230     Document Type: Conference Paper

References (16)

1. Duncan MO, Bilgeri YR, Fehler HG, Ballard RC. The diagnosis of sexually acquired genital ulceration in black patients in Johannesburg. S Afr J Sex Transm Dis 1981;1:20-3
2. Nsanze H, Fast MV, D'Costa LJ, Tukei P, Curran J, Ronald A. Genital ulcers in Kenya: clinical and laboratory study. Br J Vener Dis 1981;57:378-1
3. Taylor DN, Duangmani C, Suvongse C, et al. The role of Haemophilus ducreyi in penile ulcers in Bangkok, Thailand. Sex Transm Dis 1984;11:148-51
4. Tan U, Rajan VS, Koe SL, Tan NJ, Tan BH, Goh AJ. Chancroid: a study of 500 cases. Asian J Infect Dis 1977;1:27-8
5. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men. Lancet 1989;ii:403-7
6. Albritton WL, Brunton JL, Slaney, L, MacLean I. Plasmid mediated sulfonamide resistance in Haemophilus ducreyi. Antimicrob Agents Chemother 1982;21:159-65
7. Abeck D, Johnson AP, Dangor Y, Ballard RC. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from Southern Africa. J Antimicrob Chemother 1988;22:437-44
8. World Health Organization. Management of sexually transmitted diseases. WHO/GPA/TEM/94.1.1994
9. Slaney L, Chubb H, Ronald A, Brunham R. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi and Chlamydia trachomatis. J Antimicrob Chemother 1990;25(Suppl. A): 109-14
10. Lukehart SA, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J Antimicrob Chemother 1940; 25(suppl. A):11-14
11. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycyline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991;2:248-51
12. Tyndall MW, Agoki E, Plummer FA, et al. Single dose azithromycin for treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994;21:231-4
13. Kilian M. A Taxonomic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol 1976;93:9-62
14. Ballard RC, Duncan MO, Fehler HG, et al. Treating chancroid: summary of studies in Southern Africa. Genitourin Med 1989;65:54-7
15. MacDonald KC, Cameron DW, D'Costa LJ, et al. Evaluation of fleroxacin (R023-6240) as single dose therapy of culture-proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989;33:612-14
16. Tyndall M, Malisa M, Plummer FA, et al. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993;167:469-71